Form 8-K - Current report:
SEC Accession No. 0001467154-22-000115
Filing Date
2022-08-11
Accepted
2022-08-11 06:35:23
Documents
14
Period of Report
2022-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novn-20220811.htm   iXBRL 8-K 38210
2 EX-99.1 a8112022exhibit991.htm EX-99.1 93474
6 logoa.jpg GRAPHIC 17861
  Complete submission text file 0001467154-22-000115.txt   304579

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT novn-20220811.xsd EX-101.SCH 1893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT novn-20220811_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT novn-20220811_pre.xml EX-101.PRE 12502
8 EXTRACTED XBRL INSTANCE DOCUMENT novn-20220811_htm.xml XML 11241
Mailing Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703 919-485-8080
Novan, Inc. (Filer) CIK: 0001467154 (see all company filings)

EIN.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37880 | Film No.: 221153564
SIC: 2834 Pharmaceutical Preparations